Trial Profile
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Toviaz (Registered)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2017
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 22 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Apr 2009 New trial record